Discover GRAIL’s MCED screening tests, Illumina’s divestiture impact, and an $8B valuation base with TAM upside tied to FDA ...

A three-year clinical trial seeks to find out if a simple blood test can detect cancer in senior citizens. The post Can a ...

FILE PHOTO: The offices of gene sequencing company Illumina Inc are shown in San Diego, California (Reuters) -Shares of Grail fell as much as 13.7% in their market debut on Tuesday after being spun ...

MENLO PARK, Calif.--(BUSINESS WIRE)--GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, today announced that detailed findings from the PATHFINDER study of ...

Shares of Grail have quintupled this year to nearly $90, as investors waited for news about the Pathfinder 2 study of its cancer-detecting blood test. Management hinted this summer the numbers were ...

Most cancer deaths occur in organs without routine screening tests available. GRAIL's Galleri blood test aims to find these ...

San Diego gene-sequencing giant Illumina said Monday that its board approved the spinoff of early cancer-detecting startup Grail. The move brings the local biotechnology company one step closer to ...

MENLO PARK, Calif., Feb. 25, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL) a healthcare company whose mission is to detect cancer early when it can be cured, has partnered with award-winning actress ...

Early-stage cancer detection startup Grail, which has investors including Amazon CEO Jeff Bezos, has filed to go public, according to a Sept. 9 CNBC report. 1. DNA-sequencing machine developer ...

GRAIL shares started trading on Nasdaq after a spin-off from Illumina, as the EU's regulatory scrutiny weighed on the prior merger. The company offers the Galleri blood test for early cancer detection ...

GRAIL, Inc. is a healthcare company whose mission is to detect cancer early when it can be cured. (PRNewsfoto/GRAIL, Inc.) GRAIL’s Galleri Test Now Directly Available to Physicians in the U.S. Through ...

CHICAGO -- Hundreds of people using the test company Grail were wrongly told they might have cancer, the company said in a statement Monday. Grail said a software glitch related to their telemedicine ...